Literature DB >> 18235140

Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study.

Jeffrey J Fadrowski1, Christopher B Pierce, Stephen R Cole, Marva Moxey-Mims, Bradley A Warady, Susan L Furth.   

Abstract

BACKGROUND AND OBJECTIVES: The level of glomerular filtration rate at which hemoglobin declines in chronic kidney disease is poorly described in the pediatric population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This cross-sectional study of North American children with chronic kidney disease examined the association of glomerular filtration rate, determined by the plasma disappearance of iohexol, and hemoglobin concentration.
RESULTS: Of the 340 patients studied, the mean age was 11 +/- 4 yr, the mean glomerular filtration rate was 42 +/- 14 ml/min per 1.73 m(2), and the mean hemoglobin was 12.5 +/- 1.5. Below a glomerular filtration rate of 43, the hemoglobin declined by 0.3 g/dl (95% confidence interval -0.2 to -0.5) for every 5-ml/min per 1.73 m(2) decrease in glomerular filtration rate. Above a glomerular filtration rate of 43 ml/min per 1.73 m(2), the hemoglobin showed a nonsignificant decline of 0.1 g/dl for every 5-ml/min per 1.73 m(2) decrease in glomerular filtration rate.
CONCLUSIONS: In pediatric patients with chronic kidney disease, hemoglobin declines as an iohexol-determined glomerular filtration rate decreases below 43 ml/min per 1.73 m(2). Because serum creatinine-based estimated glomerular filtration rates may overestimate measured glomerular filtration rate in this population, clinicians need to be mindful of the potential for hemoglobin decline and anemia even at early stages of chronic kidney disease, as determined by current Schwartz formula estimates. Future longitudinal analyses will further characterize the relationship between glomerular filtration rate and hemoglobin, including elucidation of reasons for the heterogeneity of this association among individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18235140      PMCID: PMC2390950          DOI: 10.2215/CJN.03020707

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  13 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  A practical guide to dose-response analyses and risk assessment in occupational epidemiology.

Authors:  Kyle Steenland; James A Deddens
Journal:  Epidemiology       Date:  2004-01       Impact factor: 4.822

3.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

4.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

Review 5.  Why is erythropoietin made in the kidney? The kidney functions as a critmeter.

Authors:  S Donnelly
Journal:  Am J Kidney Dis       Date:  2001-08       Impact factor: 8.860

6.  Relationship between hematocrit and renal function in men and women.

Authors:  C Y Hsu; D W Bates; G J Kuperman; G C Curhan
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

7.  Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure.

Authors:  M Chandra; G K Clemons; M I McVicar
Journal:  J Pediatr       Date:  1988-12       Impact factor: 4.406

8.  Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994).

Authors:  Brad C Astor; Paul Muntner; Adeera Levin; Joseph A Eustace; Josef Coresh
Journal:  Arch Intern Med       Date:  2002-06-24

9.  Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.

Authors:  R J McGonigle; F G Boineau; B Beckman; K Ohene-Frempong; J E Lewy; R K Shadduck; J W Fisher
Journal:  J Lab Clin Med       Date:  1985-04

10.  Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study.

Authors:  Susan L Furth; Stephen R Cole; Marva Moxey-Mims; Frederick Kaskel; Robert Mak; George Schwartz; Craig Wong; Alvaro Muñoz; Bradley A Warady
Journal:  Clin J Am Soc Nephrol       Date:  2006-07-19       Impact factor: 8.237

View more
  30 in total

1.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

2.  A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.

Authors:  Debora C Cerqueira; Cristina M Soares; Vanessa R Silva; Juliana O Magalhães; Isabella P Barcelos; Mariana G Duarte; Sergio V Pinheiro; Enrico A Colosimo; Ana Cristina Simões e Silva; Eduardo A Oliveira
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

Review 3.  Chronic Kidney Disease and Dietary Measures to Improve Outcomes.

Authors:  Oleh M Akchurin
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

4.  Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease.

Authors:  Amy C Wilson; Michael F Schneider; Christopher Cox; Larry A Greenbaum; Jeffrey Saland; Colin T White; Susan Furth; Bradley A Warady; Mark M Mitsnefes
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

5.  Vitamin D, race, and risk for anemia in children.

Authors:  Meredith A Atkinson; Michal L Melamed; Juhi Kumar; Cindy N Roy; Edgar R Miller; Susan L Furth; Jeffrey J Fadrowski
Journal:  J Pediatr       Date:  2013-10-08       Impact factor: 4.406

Review 6.  CKiD (CKD in children) prospective cohort study: a review of current findings.

Authors:  Cynthia J Wong; Marva Moxey-Mims; Judith Jerry-Fluker; Bradley A Warady; Susan L Furth
Journal:  Am J Kidney Dis       Date:  2012-09-28       Impact factor: 8.860

Review 7.  Cardiovascular complications in children with chronic kidney disease.

Authors:  Rukshana Shroff; Donald J Weaver; Mark M Mitsnefes
Journal:  Nat Rev Nephrol       Date:  2011-09-13       Impact factor: 28.314

8.  Iron deficiency in children with early chronic kidney disease.

Authors:  Rossana Baracco; Sermin Saadeh; Rudolph Valentini; Gaurav Kapur; Amrish Jain; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2011-06-28       Impact factor: 3.714

Review 9.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

Review 10.  Risk factors for progression of chronic kidney disease.

Authors:  Amy Staples; Craig Wong
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.